Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients

Trial Profile

Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Masilukast (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors SAMA Pharmaceuticals
  • Most Recent Events

    • 20 Nov 2015 Last checked against ClinicalTrials.gov record.
    • 13 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 18 Jan 2015 Planned primary completion date changed from 1 Jan 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top